The U.S. Preventive Services Task Force today recommended clinicians offer pre-exposure prophylaxis (PrEP), a pill that helps prevent the spread of HIV, to high-risk patients. High-risk behaviors include having a sex partner with HIV, having sex without a condom with a partner at high risk for HIV and sharing needles or other equipment while injecting drugs, the panel said. PrEP is highly effective at preventing HIV if taken daily, but people who take the pill should continue to use condoms and practice other behaviors to reduce their risk of other sexually transmitted infections, the task force said. It also continued to recommend that clinicians screen for HIV in pregnant women, everyone aged 15 to 65, and others at increased risk for HIV. The panel assigned an “A" grade to the recommendations, meaning all copays and deductibles would be waived under the Affordable Care Act.

Headline
There are now 17,180 confirmed cases of cyclosporiasis in the U.S., the Centers for Disease Control and Prevention reported Aug. 25. At least 11,844 additional…
Headline
In this conversation, Kardie Tobb, D.O., a non-invasive preventative cardiologist at Cone Health, explains how multidisciplinary teams are breaking down…
Headline
There have been 15,716 confirmed cases of cyclosporiasis across 47 states, Washington, D.C., and Puerto Rico since May 1, the Centers for Disease Control and…
Headline
The Common Health Coalition announced Aug. 13 that it will receive $100 million in funding from the OpenAI Foundation for a new initiative using artificial…
Headline
The Centers for Disease Control and Prevention Aug. 11 released a health advisory on the risk of severe arboviral disease among patients receiving B-cell-…
Headline
The Centers for Disease Control and Prevention yesterday announced that the ongoing cyclosporiasis outbreak linked to iceberg lettuce has expanded to 15 states…